These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 14968733)
1. A prediction model to identify risk of developing Stevens-Johnson syndrome or toxic epidermal necrolysis in patients with erythema multiforme. Tham LS; Tambyah PA Ann Acad Med Singap; 2003 Sep; 32(5 Suppl):S46-8. PubMed ID: 14968733 [No Abstract] [Full Text] [Related]
2. Analysis of the acute ophthalmic manifestations of the erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis disease spectrum. Power WJ; Ghoraishi M; Merayo-Lloves J; Neves RA; Foster CS Ophthalmology; 1995 Nov; 102(11):1669-76. PubMed ID: 9098260 [TBL] [Abstract][Full Text] [Related]
3. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study. Auquier-Dunant A; Mockenhaupt M; Naldi L; Correia O; Schröder W; Roujeau JC; Arch Dermatol; 2002 Aug; 138(8):1019-24. PubMed ID: 12164739 [TBL] [Abstract][Full Text] [Related]
5. Stevens-Johnson syndrome and toxic epidermal necrolysis at the University Hospital of the West Indies, Jamaica. East-Innis AD; Thompson DS West Indian Med J; 2013 Sep; 62(7):589-92. PubMed ID: 24831894 [TBL] [Abstract][Full Text] [Related]
6. Stevens-Johnson syndrome and toxic epidermal necrolysis are severity variants of the same disease which differs from erythema multiforme. Roujeau JC J Dermatol; 1997 Nov; 24(11):726-9. PubMed ID: 9433029 [TBL] [Abstract][Full Text] [Related]
7. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Association with Commonly Prescribed Drugs in Outpatient Care Other than Anti-Epileptic Drugs and Antibiotics: A Population-Based Case-Control Study. Frey N; Bodmer M; Bircher A; Jick SS; Meier CR; Spoendlin J Drug Saf; 2019 Jan; 42(1):55-66. PubMed ID: 30112729 [TBL] [Abstract][Full Text] [Related]
9. Head and neck manifestations of erythema multiforme in children. Stewart MG; Duncan NO; Franklin DJ; Friedman EM; Sulek M Otolaryngol Head Neck Surg; 1994 Sep; 111(3 Pt 1):236-42. PubMed ID: 8084631 [TBL] [Abstract][Full Text] [Related]
10. Oculocutaneous manifestations of the erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum. Wilkins J; Morrison L; White CR Dermatol Clin; 1992 Jul; 10(3):571-82. PubMed ID: 1617814 [TBL] [Abstract][Full Text] [Related]
12. Relevance and consequences of erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in gynecology. Niemeijer IC; van Praag MC; van Gemund N Arch Gynecol Obstet; 2009 Nov; 280(5):851-4. PubMed ID: 19277691 [TBL] [Abstract][Full Text] [Related]
13. A systematic review of validated methods for identifying erythema multiforme major/minor/not otherwise specified, Stevens-Johnson Syndrome, or toxic epidermal necrolysis using administrative and claims data. Schneider G; Kachroo S; Jones N; Crean S; Rotella P; Avetisyan R; Reynolds MW Pharmacoepidemiol Drug Saf; 2012 Jan; 21 Suppl 1():236-9. PubMed ID: 22262611 [TBL] [Abstract][Full Text] [Related]
14. Histopathological and epidemiological characteristics of patients with erythema exudativum multiforme major, Stevens-Johnson syndrome and toxic epidermal necrolysis. Rzany B; Hering O; Mockenhaupt M; Schröder W; Goerttler E; Ring J; Schöpf E Br J Dermatol; 1996 Jul; 135(1):6-11. PubMed ID: 8776350 [TBL] [Abstract][Full Text] [Related]
15. Seasonal variation of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with trimethoprim-sulfamethoxazole. Kelly JP; Kaufman DW; Dunant A; Mockenhaupt M; Roujeau JC J Am Acad Dermatol; 2011 Jun; 64(6):1193-4. PubMed ID: 21571188 [No Abstract] [Full Text] [Related]
16. Erythema multiforme: a review and contrast from Stevens-Johnson syndrome/toxic epidermal necrolysis. Williams PM; Conklin RJ Dent Clin North Am; 2005 Jan; 49(1):67-76, viii. PubMed ID: 15567361 [TBL] [Abstract][Full Text] [Related]
17. Stevens-Johnson syndrome associated with ciprofloxacin: a review of adverse cutaneous events reported in Sweden as associated with this drug. Hällgren J; Tengvall-Linder M; Persson M; Wahlgren CF J Am Acad Dermatol; 2003 Nov; 49(5 Suppl):S267-9. PubMed ID: 14576649 [TBL] [Abstract][Full Text] [Related]